Posts Categorized: MS News

  Source Guardian: With Nice announcing its latest guidelines on drugs and clinical care, the Guardian’s health editor is joined by an expert panel to discuss the implications for those who suffer from MS. Sarah is joined in studio by Professor Mark Baker, d…irector of the centre for clinical practice at Nice, Dr Paul Cooper,… Read more »

In April, NICE rejected two of the only symptom management treatments specifically licensed for MS. We know that access to these treatments is a priority for many people with MS and we have anecdotal evidence that with these treatments unavailable, some people are turning to alternative or unlicensed options. We need to hear from you… Read more »

Source: Rutgers:   Yoga Relieves Multiple Sclerosis Symptoms, Rutgers Study Finds. Please contact Sue if you are interested. “Paula Meltzer was only 38 when out of nowhere everything she looked at was blurry. For the single mother, who had a lucrative career as a gemologist and spent hours examining valuable pieces of jewellrey, it seemed… Read more »

Dimethyl fumarate (BG-12, Tecfidera) will start to be available on the NHS in England and Wales from November following final guidance from NICE (National Institute for Health and Care Excellence). Dimethyl fumarate is approved as a treatment for adults with active relapsing remitting multiple sclerosis (normally defined as two clinically significant relapses in the previous… Read more »

Source MS Society: Now that the Care Act has been agreed by the Queen (gained Royal Assent), the Government has been drafting new regulations and guidance that outline how local authorities should put the Act into practice. Read on.

Source: Economist IN SCIENCE, as in many other walks of life, what is unexpected is often what is most interesting and important. The idea, first mooted in 2011 by Julian Gold of the Prince of Wales Hospital in Sydney, Australia, that HIV infection—or maybe the drug treatment used to fight it—might protect against multiple sclerosis… Read more »

The Cochrane MS Group is working to identify research priorities for Multiple Sclerosis, on risk factors for the disease, prevention, treatments, rehabilitation, palliative care, prognosis and accuracy of diagnostic tests, to guide future activities mainly in term of new and updated reviews. For further information take a look at their website here

Source: The Telegraph Scientists believe they are close to developing a drug which could ‘switch off’ autoimmune diseases like Multiple sclerosis by training the body to stop attacking itself read more  

The MS Society would like to hear your views and experiences about ways information about MS can best be made available in health and social care settings, and the support that you need in order for it to happen. By completing our survey https://www.surveymonkey.com/s/mssocietyinfopoints you will contribute to forming recommendations for the future of our work… Read more »

MS Trust Annual Conference Chesford Grange, Kenilworth, Warwickshire 9 – 11 November 2014 The MS Trust Annual Conference, the flagship event for health and care professionals working with people with MS, runs from 9–11 November at Chesford Grange, Kenilworth. The programme is varied, current and aims to offer something for everyone. We are looking forward… Read more »